Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 212295

BYFAVO (REMIMAZOLAM BESYLATE)
EQ 20MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: REMIMAZOLAM BESYLATE
Proprietary Name: BYFAVO
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 20MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N212295
Product Number: 001
Approval Date: Jul 2, 2020
Applicant Holder Full Name: ACACIA PHARMA LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English